Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M801923200 on April 8, 2008

J. Biol. Chem., Vol. 283, Issue 23, 15589-15600, June 6, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
283/23/15589    most recent
M801923200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fuhrken, P. G.
Right arrow Articles by Papoutsakis, E. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fuhrken, P. G.
Right arrow Articles by Papoutsakis, E. T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Tumor Suppressor Protein p53 Regulates Megakaryocytic Polyploidization and Apoptosis*Formula

Peter G. Fuhrken{ddagger}1, Pani A. Apostolidis{ddagger}§2, Stephan Lindsey§, William M. Miller{ddagger}, and Eleftherios T. Papoutsakis{ddagger}§3

From the {ddagger}Department of Chemical and Biological Engineering, Northwestern University, Evanston, Illinois 60208 and the §Department of Chemical Engineering and the Delaware Biotechnology Institute, University of Delaware, Newark, Delaware 19711

The molecular mechanisms underlying differentiation of hematopoietic stem cells into megakaryocytes are poorly understood. Tumor suppressor protein p53 can act as a transcription factor affecting both cell cycle control and apoptosis, and we have previously shown that p53 is activated during terminal megakaryocytic (Mk) differentiation of the CHRF-288-11 (CHRF) cell line. Here, we use RNA interference to reduce p53 expression in CHRF cells and show that reduced p53 activity leads to a greater fraction of polyploid cells, higher mean and maximum ploidy, accelerated DNA synthesis, and delayed apoptosis and cell death upon phorbol 12-myristate 13-acetate-induced Mk differentiation. In contrast, reduced p53 expression did not affect the ploidy or DNA synthesis of CHRF cells in the absence of phorbol 12-myristate 13-acetate stimulation. Furthermore, primary Mk cells from cultures initiated with p53-null mouse bone marrow mononuclear cells displayed higher ploidy compared with wild-type controls. Quantitative reverse transcription-PCR analysis of p53-knockdown CHRF cells, compared with the "scrambled" control CHRF cells, revealed that six known transcriptional targets of p53 (BBC3, BAX, TP53I3, TP53INP1, MDM2, and P21) were down-regulated, whereas BCL2 expression, which is known to be negatively affected by p53, was up-regulated. These studies show that the functional role of the intrinsic activation of p53 during Mk differentiation is to control polyploidization and the transition to endomitosis by impeding cell cycling and promoting apoptosis.


Received for publication, March 10, 2008

* This work was supported, in whole or in part, by National Institutes of Health Grant HL48276. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Tables S1 and S2.

1 Supported by a National Science Foundation Graduate Research Fellowship.

2 Supported by the A. S. Onassis Foundation.

3 To whom correspondence should be addressed: Delaware Biotechnology Institute, University of Delaware, 15 Innovation Way, Newark, DE 19711. Fax: 302-831-4841; E-mail: papoutsakis{at}dbi.udel.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Cell Sci.Home page
Z. Storchova and C. Kuffer
The consequences of tetraploidy and aneuploidy
J. Cell Sci., December 1, 2008; 121(23): 3859 - 3866.
[Abstract] [Full Text] [PDF]


Home page
ASH ANNUAL MEETING ABSTRACTSHome page
P. A. Apostolidis, A. Duchoud, S. Lindsey, W. M. Miller, and E. Papoutsakis
Tumor Suppressor Protein p53 Affects Megakaryocytic Maturation: In Vivo and Ex Vivo Post-Translational Modification Studies
Blood (ASH Annual Meeting Abstracts), November 16, 2008; 112(11): 2443 - 2443.
[Abstract]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement